Related Experiment Videos
Fit-for-purpose method development and validation for successful biomarker measurement
Jean W Lee1, Viswanath Devanarayan, Yu Chen Barrett
1Formerly MDS Pharma Services, Lincoln, Nebraska, USA. jwlee@amgen.com
Pharmaceutical Research
|January 7, 2006
Summary
A "fit-for-purpose" approach to biomarker method validation is proposed to address challenges in drug development. This strategy aims to accelerate new drug approvals by improving biomarker data interpretation and regulatory clarity.
Area of Science:
- Biomarker research
- Drug development
- Regulatory science
Background:
- Modern drug discovery faces rising costs and slow approval rates.
- Biomarkers offer potential to expedite drug development but face adoption hurdles.
- Limited experience in biomarker data interpretation and regulatory uncertainty impede widespread use.
Purpose of the Study:
- To address critical issues in biomarker method development and validation.
- To propose a practical approach for biomarker implementation in drug development.
- To facilitate the adoption of biomarkers by clarifying validation paradigms.
Main Methods:
- Review of challenges in biomarker validation based on the AAPS 2003 Biomarker Workshop.
- Development of a "fit-for-purpose" iterative approach for biomarker method development.
- Consideration of intended data use and regulatory requirements in validation.
Main Results:
- A practical, iterative "fit-for-purpose" approach to biomarker method development and validation is proposed.
- This approach addresses limitations in current validation paradigms for biomarker research.
- Successful biomarker implementation is facilitated by context-specific validation.
Conclusions:
- The proposed "fit-for-purpose" approach enhances biomarker data interpretation and regulatory compliance.
- This strategy supports increased utilization of biomarkers in drug development pipelines.
- Improved biomarker validation is key to accelerating the delivery of new therapeutics.